Merck Manual

Please confirm that you are a health care professional

honeypot link

Variably Protease-Sensitive Prionopathy (VPSPr)


Pierluigi Gambetti

, MD, Case Western Reserve University

Last full review/revision Jul 2020| Content last modified Jul 2020
Click here for Patient Education

Variably protease-sensitive prionopathy (VPSPr) is a rare sporadic prion disease (identified in 2008).

Variably protease-sensitive prionopathy occurs in 1 to 2/100 million people.

VPSPr resembles Gerstmann-Sträussler-Scheinker disease (GSS) in terms of the characteristics of the abnormal prion protein (PrPSc). However, unlike in GSS, no mutations in the prion protein gene have been identified.

Clinical manifestations differ from those of Creutzfeldt-Jakob disease, and the PrPSc is less resistant to digestion by proteases; some variants are more sensitive to proteases than others, hence the name: variably protease-sensitive.

Patients present with psychiatric symptoms, speech deficits (aphasia and/or dysarthria), and cognitive impairment. Ataxia and parkinsonism can develop. Average age at onset is 70 years, and duration of survival is 24 months. About 40% of patients have a family history of dementia.

Diagnosis of variably protease-sensitive prionopathy is difficult. MRI, EEG, and tests for 14-3-3 protein and tau are usually not helpful, and no mutations have been observed in the coding region of the PrP gene.

There is only supportive treatment for VPSPr.

Click here for Patient Education
NOTE: This is the Professional Version. CONSUMERS: Click here for the Consumer Version
Professionals also read

Also of Interest

Download the Manuals App iOS ANDROID
Download the Manuals App iOS ANDROID
Download the Manuals App iOS ANDROID